KI
RMD icon

Kula Investments’s ResMed RMD Stock Holding History

Kula Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$487K Sell
2,223
-4,234
-66% -$919K 0.12% 310
2022
Q4 		$1.34M Buy
+6,457
New +$1.42M 0.4% 18

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kula Investments's RMD Position: Q1 2023 in Review

Kula Investments reduced its ResMed (RMD) stake by 66% in Q1 2023, selling an estimated $919K and leaving 2,223 shares worth $487K. The position accounts for 0.12% of the portfolio, ranked #310.

Kula Investments first reported a position in RMD in Q4 2022 and has held it in 2 quarters since. The position peaked at $1.34M in Q4 2022. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Kula Investments held 2,223 shares of ResMed worth $487K as of Q1 2023.
  • Kula Investments sold 4,234 ResMed shares in Q1 2023, an estimated $919K.
  • ResMed made up 0.12% of Kula Investments's portfolio in Q1 2023, its #310 holding.
  • Kula Investments first reported a position in ResMed in Q4 2022 and has held it in 2 quarters since.
  • Kula Investments's ResMed position peaked at $1.34M in Q4 2022.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.